logo

Last Update

This profile was last updated on 8/17/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Derek LeRoith?

Derek LeRoith

Director of Research

Mount Sinai School of Medicine

HQ Phone:  (212) 241-6500

Direct Phone: (212) ***-****direct phone

Email: d***@***.edu

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Mount Sinai School of Medicine

Box 1497 , One Gustave L. Levy Place

New York City, New York,10029

United States

Company Description

Located in Manhattan, Mount Sinai School of Medicine is internationally recognized for ground-breaking clinical and basic-science research, and innovative approaches to medical education. Through the Mount Sinai Graduate School of Biological Sciences, Mount Si...more

Background Information

Employment History

Consultant

Takeda Pharmaceuticals North America , Inc.


Director of Research, Division of Endocrinology

Icahn School of Medicine at Mount Sinai


Director

Ministry of Health Israel


Chief, Division of Endocrinology, Diabetes and Bone Disease, Professor of Medicine

Mount Sinai Hospital


Diabetes Branch Chief

National Institutes of Health


Affiliations

American Diabetes Association

Member of the National Board of Directors


AstraZeneca PLC

Advisory Board


Royal College of Physicians

Member


IGF Society

Council Member


College of Physicians of South Africa

Fellow


Endocrine Fellows Foundation

Board Member


Oramed Pharmaceuticals Inc.

Scientific Advisory Board Member


Amylin Pharmaceuticals , Inc.

Advisory Boards Member


Oramed Pharmaceuticals Inc.

Member of Scientific Advisory Board


WellGen , Inc.

Scientific Advisory Board Member


Foundation for Advanced Education in the Sciences

Board Member


Consultant/Speakers Bureau

Advisory Board Member


Medingo

Scientific Advisory Board Member


Gordon Research Conferences incorporated

Board of Trustees Member


Bristol-Myers Squibb Company

Speaker and Advisory Board


CaringForDiabetes.com

Faculty Council Member


Medscape LLC

Board Member


Harcourt International

Board Member


PhD-Janssen Pharmaceuticals , Inc.

Advisory Board


the United States Department of Veterans Affairs

Review Committees


Vicrin LLC

Advisory Board Member


Harcourt Publishers Ltd

Board Member


University of Cincinnati College of Medicine

Member of the Faculty


Ben-Gurion University Medical School

Member of the Medical Faculty


Education

M.D.


MD

American College of Endocrinology Distinction


Ph.D.

University of Cape Town


Ph.D.

The University of Capetown


PhD

Icahn School of Medicine at Mount Sinai


PhD

Department of Medicine

Mount Sinai School of Medicine


Web References(166 Total References)


Online CME Credits at WebBasedCME.com :: Learn at Your Speed

www.webbasedcme.com [cached]

Derek LeRoith, MD, PhD
Speakers Bureau: Merck, Novo Nordisk Inc, Pfizer Inc, sanofi-aventis, Takeda Pharmaceutical Company Limited Consultant: Pfizer Inc, sanofi-aventis Dr LeRoith discloses that he does not anticipate referencing unlabeled/unapproved uses of drugs or products in his presentation. Picture of Derek LeRoith, MD, PhD Derek LeRoith, MD, PhD Professor of Medicine and Endocrinology Chief, Division of Endocrinology, Diabetes, and Bone Disease Mount Sinai School of Medicine Derek LeRoith, MD, PhD, is Chief of the Division of Endocrinology, Diabetes, and Bone Disease, Department of Medicine, Mount Sinai School of Medicine. Dr LeRoith earned his MB ChB in 1967 and his PhD in 1973, both from the University of Cape Town in South Africa. He became a Fellow of the College of Physicians of South Africa in 1974 and a Member of the Royal College of Physicians in the United Kingdom in 1975. Dr LeRoith is a recognized leader in the field of diabetes and endocrinology, having served as the Chief of the Diabetes Branch of the National Institutes of Diabetes, Digestive and Kidney Diseases from 1999 to 2005. He has also been a member of the National Board of Directors for the American Diabetes Association. He has authored over 500 publications in the area of endocrinology and has served on the editorial boards of numerous journals, including Growth Hormone & IGF Research, Diabetes/Metabolism Research and Reviews, and Endocrine Clinics of North America. Derek LeRoith, MD, PhD


Online CME Credits at WebBasedCME.com :: Learn at Your Speed

www.webbasedcme.com [cached]

Derek LeRoith, MD, PhD
Professor of Medicine Chief of the Division of Endocrinology, Diabetes and Bone Disease Mount Sinai School of Medicine Derek LeRoith, MD, PhD Derek LeRoith, MD, PhD Advisory Board: AstraZeneca; Bristol-Myers Squibb; Merck & Co, Inc; sanofi-aventis U.S. LLC. Consultant: AstraZeneca; Bristol-Myers Squibb; Merck & Co, Inc; sanofi-aventis U.S. LLC Dr LeRoith has disclosed that he will be discussing investigational uses of therapies, products, or devices.


www.caringfordiabetes.com

Derek LeRoith, MD, PhD - Chairperson
Chief, Division of Endocrinology, Diabetes and Bone Disease Professor of Medicine Mount Sinai School of Medicine Derek LeRoith, MD, PhD - Chairperson Research Activities: Novartis; sanofi-aventis Speakers Bureau: AstraZeneca Pharmaceuticals; Bristol-Myers Squibb; Merck & Co, Inc; sanofi-aventis Dr LeRoith has disclosed that he does not anticipate discussing off-label or investigational uses of any products.


www.caringfordiabetes.com

Derek LeRoith, MD, PhD, FACP
Chief, Division of Endocrinology, Diabetes, and Bone Disease Professor of Medicine Mount Sinai School of Medicine Dr LeRoith has received consulting fees from Merck & Co, Inc and Bristol-Myers Squibb & Company /AstraZeneca Pharmaceuticals, and speaker honoraria from Merck & Co, Inc, Novo Nordisk, Inc, and Takeda Pharmaceuticals North America, Inc.


Optimizing Cardiovascular Outcomes in Type 2 Diabetes WebCAST

www.clinicalwebcasts.com [cached]

DEREK LEROITH, MD, PhD
Director of Research Mount Sinai School of Medicine


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory